Thousands of premature babies at risk of life-threatening infection can now be protected against the common respiratory syncytial virus (RSV) this winter, with a single long-lasting injection available on the NHS for the first time. The NHS in England is rolling out drug nirsevimab from late September to provide protection against RSV to around 7,000 […]

Hospitals will be able to address unfair elective waits for working class and minority patients as new data published today shows those from deprived communities are more likely to wait longer. Data published for the first time ever by the NHS show patients in the poorest communities and those from an Asian or Asian British […]

Hundreds of patients in East London are set to benefit as the NHS opened its first 24/7 neighbourhood mental health centre today – a key commitment under the 10 Year Health Plan – offering walk-in support for people with mental illness. Tower Hamlets in East London is the first community to benefit as the NHS […]

The agenda and papers for the NHS England board meeting on 17 July 2025.

Many of the papers below are published as accessible web content, however, some have been published in PDF format. If you require these in an alternative format please email england.boardsecretariat@nhs.net

NHS federated data platform (NHS FDP) product data protection impact assessment for the NHS FDP national ontology product.

Letters from Dr Claire Fuller, Co-National Medical Director, (Primary Care), NHS England and Professor Meghana Pandit, Co-National Medical Director (Secondary Care), NHS England in response to the recommendations of the Independent Review of Physician Associates and Anaesthesia Associates (the Leng Review)

NHS England has confirmed that vanzacaftor–tezacaftor–deutivacaftor will be made available as a treatment option for people with cystic fibrosis (CF) who have 1 of an expanded range of CF transmembrane conductance regulator mutations within the criteria set out in this commissioning statement.

Hundreds of children and adults with rare forms of cystic fibrosis in England will be able to access “life-changing” new ‘triple-combination’ therapy for the very first time, the NHS has announced. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation of therapies to be made available on the NHS that help treat the underlying cause […]

NHS Commercial guidance on applying social value in the procurement of NHS goods and services. NHS England’s stated policy objective is to meet its net zero carbon targets while achieving its wider social value priorities. Delivery of meaningful social value through our contractual commitments can truly tackle health and economic inequalities and improve outcomes in […]

NHS Commercial guidance on applying social value in the procurement of NHS goods and services.

NHS England’s stated policy objective is to meet its net zero carbon targets while achieving its wider social value priorities. Delivery of meaningful social value through our contractual commitments can truly tackle health and economic inequalities and improve outcomes in our communities. The playbook provides guidance for each stage of the procurement or commissioning lifecycles.

It covers question setting, evaluation, and contract management to build confidence across commercial teams and our supply chain.